These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13835653)

  • 1. The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine).
    SULLIVAN RD; YOUNG CW; MILLER E; GLATSTEIN N; CLARKSON B; BURCHENAL JH
    Cancer Chemother Rep; 1960 Jul; 8():77-83. PubMed ID: 13835653
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report.
    YOUNG CW; ELLISON RR; SULLIVAN RD; LEVICK SN; KAUFMAN R; MILLER E; WOLDOW I; ESCHER G; LI MC; KARNOFSKY DA; BURCHENAL JH
    Cancer Chemother Rep; 1960 Feb; 6():17-20. PubMed ID: 13846613
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in the treatment of far-advanced breast and colon lesions.
    CURRERI AR; ANSFIELD FJ
    Cancer Chemother Rep; 1962 Feb; 16():387-8. PubMed ID: 13882717
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of the pyrimidine nucleosides 5-fluoro-2'-deoxyuridine and 5-iodo-2'-deoxyuridine.
    PAPAC R; JACOBS E; WONG F; COLLOM A; SKOOG W; WOOD DA
    Cancer Chemother Rep; 1962 Jul; 20():143-6. PubMed ID: 14483657
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical evaluation of 5-fluoro-2'-deoxyuridine in acute leukemia in children.
    HARTMANN JR; ERLANDSON M; MURPHY ML; ORIGENES ML; SITARZ A
    Cancer Chemother Rep; 1960 Jul; 8():84-96. PubMed ID: 14400172
    [No Abstract]   [Full Text] [Related]  

  • 6. A preliminary comparison of 5-fluoro-2'-deoxyuridine administered by rapid daily intravenous injections and by slow continuous infusion.
    ANSFIELD FJ; SCHROEDER JM; CURRERI AR
    Cancer Chemother Rep; 1962 Feb; 16():389-90. PubMed ID: 13861732
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with 5-fluoro-2'-deoxyuridine.
    MOORE GE; KOIKE A
    Cancer Chemother Rep; 1960 Feb; 6():26-8. PubMed ID: 14423850
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical studies with 5-fluoro-2'-deoxyuridine.
    ANSFIELD FJ; CURRERI AR
    Cancer Chemother Rep; 1960 Feb; 6():21-5. PubMed ID: 13793784
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial clinical studies with 5-iodo-2'-deoxyuridine.
    CALABRESI P; CARDOSO SS; FINCH SC; KLIGERMAN MM; VON ESSEN CF; CHU MY; WELCH AD
    Cancer Res; 1961 May; 21():550-9. PubMed ID: 13689863
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine.
    KAUFMAN HE
    Proc Soc Exp Biol Med; 1962 Feb; 109():251-2. PubMed ID: 14454445
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of 5-fluorouracil (FU), 5-fluorodeoxyuridine (FUDR), and methotrexate (MTX)-progress report.
    HALL TC
    Cancer Chemother Rep; 1962 Feb; 16():391-6. PubMed ID: 13903907
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional protection in cancer chemotherapy. II. Preliminary studies with hypogastric artery infusion of thymidine during treatment with 5-iodo-2'-deoxyuridine.
    MARK JB; CALABRESI P
    Cancer Chemother Rep; 1962 Feb; 16():545-51. PubMed ID: 14469946
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on fluorinated pyrimidines. VIII. Further biochemical and metabolic investigations.
    HARBERS E; CHAUDHURI NK; HEIDELBERGER C
    J Biol Chem; 1959 May; 234(5):1255-62. PubMed ID: 13654358
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorinated pyrimidines. XII. Effects of simple nucleotides on transplanted tumors.
    HEIDELBERGER C; SUNTHANKAR AV; GRIESBACH L; RANDERSON S
    Proc Soc Exp Biol Med; 1960 May; 104():127-9. PubMed ID: 14400596
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of fluorinated pyrimidines on the growth of human tumor cells cultured in vitro].
    LEONARDI A; PALMA V
    Boll Soc Ital Biol Sper; 1959 Jul; 35():857-60. PubMed ID: 14415796
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical effects of the continuous intravenous and intra-arterial infusion of cancer chemotherapeutic compounds.
    SULLIVAN RD; MILLER E; CHRYSSOCHOOS T; WATKINS E
    Cancer Chemother Rep; 1962 Feb; 16():499-510. PubMed ID: 13918324
    [No Abstract]   [Full Text] [Related]  

  • 17. FLUORINATED PYRIMIDINES. XX. INHIBITION OF THE NUCLEOSIDE PHOSPHORYLASE CLEAVAGE OF 5-FLUORO-2'-DEOXYURIDINE BY 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.
    HEIDELBERGER C; BIRNIE GD; BOOHAR J; WENTLAND D
    Biochim Biophys Acta; 1963 Oct; 76():315-8. PubMed ID: 14097389
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of p53 status on the cytotoxicity of fluorinated pyrimidine L-nucleosides.
    Murray V; Taylor CB; Gero AM; Lutze-Mann LH
    Chem Biol Interact; 2015 Oct; 240():102-9. PubMed ID: 26296760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorinated nucleosides, nucleotides and sugar nucleotides.
    Dolan JP; Benckendorff CM; Field RA; Miller GJ
    Future Med Chem; 2023 Jul; 15(13):1111-1114. PubMed ID: 37466090
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase.
    HARTMANN KU; HEIDELBERGER C
    J Biol Chem; 1961 Nov; 236():3006-13. PubMed ID: 13905041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.